Form 4: Northrop Grumman Exec's Equity Transactions

Kathryn G. Simpson, Northrop Grumman's Corp VP & General Counsel, reported acquisitions and dispositions of common stock and new grants of restricted performance and stock rights.

Summary

• Kathryn G. Simpson, Corporate VP & General Counsel at Northrop Grumman Corp, reported changes in her beneficial ownership.
• Acquired 1,334.96 shares of common stock upon the settlement of Restricted Performance Stock Rights (RPSRs) on February 11, 2026.
• Disposed of 461 shares of common stock at a price of $678.83 per share on February 11, 2026, likely for tax withholding related to the RPSR settlement.
• Received a new grant of 3,187 unvested Restricted Performance Stock Rights (RPSRs) under the 2024 Long-Term Incentive Stock Plan (LTISP) on February 11, 2026, with a measurement period ending December 31, 2028.
• Received a new grant of 1,471 Restricted Stock Rights (RSRs) under the 2024 LTISP on February 11, 2026, which will vest on February 12, 2029.
• The settlement of 2023 RPSRs (with a measurement period ended December 31, 2025) resulted in 148% of the target award being issued.
• Following these transactions, Simpson beneficially owns 1,653.39 shares of common stock, 12,579.96 Restricted Performance Stock Rights, and 5,555 Restricted Stock Rights.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively as it reflects strong performance against incentive metrics, evidenced by the 148% RPSR settlement, and continued alignment of executive interests with long-term company goals through new equity grants.

Positives

• Settlement of 2023 Restricted Performance Stock Rights (RPSRs) at 148% of the target award indicates strong performance against the applicable metrics.
• New grants of 3,187 RPSRs and 1,471 RSRs demonstrate continued long-term incentive alignment between management and shareholder interests.

Negatives

• Disposition of 461 shares of common stock, likely for tax purposes, reduces direct share ownership.

Risks

• Restricted Performance Stock Rights (RPSRs) are contingent on satisfying performance metrics, meaning the actual number of shares received could be lower if targets are not met.
• Restricted Stock Rights (RSRs) are subject to future vesting conditions, and forfeiture could occur if employment terms are not met.

Future Outlook

The grants of Restricted Performance Stock Rights (RPSRs) and Restricted Stock Rights (RSRs) extend through measurement periods ending December 31, 2028, and vesting dates through February 12, 2029, aligning executive incentives with long-term company performance.

Industry Context

StockSavvy.ai notes that executive equity compensation, particularly through performance-based awards like RPSRs and time-based awards like RSRs, is a standard practice in the defense and aerospace industry. This structure aims to align executive incentives with long-term shareholder value creation and operational performance, a common strategy among peers like Lockheed Martin and Boeing.

Comparison to Industry Standards

• The use of both performance-based (RPSRs) and time-based (RSRs) equity awards is consistent with best practices in executive compensation across major industrial and defense contractors, including peers such as Lockheed Martin (LMT) and Raytheon Technologies (RTX).
• A settlement rate of 148% for the 2023 RPSRs suggests strong performance against internal metrics, which is a positive indicator when compared to typical target achievement rates in similar incentive plans across the industry.
• The multi-year vesting and measurement periods (e.g., RPSRs through 2028, RSRs through 2029) are standard for fostering long-term commitment and strategic alignment, mirroring structures seen in companies like General Dynamics (GD) and BAE Systems.

Stakeholder Impact

• Shareholders: The strong performance leading to a 148% RPSR settlement suggests effective management and potential positive impact on shareholder value. New grants align executive incentives with long-term company performance.
• Employees (Executive): Receipt of new equity awards and settlement of previous awards provides significant compensation and incentive.

Next Steps

• Measurement period for 2024 RPSRs ends on December 31, 2026.
• Vesting date for 2023 RSRs is February 17, 2026.
• Measurement period for 2025 RPSRs ends on December 31, 2027.
• Vesting date for 2024 RSRs is February 16, 2027.
• Measurement period for 2026 RPSRs ends on December 31, 2028.
• Vesting date for 2025 RSRs is February 18, 2028.
• Vesting date for 2026 RSRs is February 12, 2029.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation activities, including the settlement of performance-based awards and new grants. While the 148% settlement rate for RPSRs is a positive indicator of past performance, these transactions are expected and do not fundamentally alter the investment thesis for Northrop Grumman. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than these specific insider transactions.

Keywords

Northrop Grumman, NOC, Insider Trading, Form 4, Restricted Stock, Performance Shares, Executive Compensation, Stock Grant, Equity Compensation